DHX15 and breast cancer: The co-IP assay exhibited that the DHX15-p65 interaction increased after inhibition of circRNF10 (Fig. 5D), demonstrating that circRNF10 competitively impaired the interaction between DHX15 and p65 via circRNF10-DHX15 interaction in BC.